Science in the SpotlightAdvances for the New Millennium
There is a fine line in medical research between hope and realism.
ReportAdvancing Alzheimer's Disease Drug Review as a National Priority
The aging of the baby boom generation continues to put more Americans at increased risk for Alzheimer's disease (AD). The need for meaningful treatment options to fight the destruction caused by AD has never been greater. This article highlights the pivotal role that the U.S. Food and Drug Administration will play in making the review of emerging AD therapies a national priority and ways that various stakeholders are engaging with regulators to meet the challenges posed by the growing AD epidemic.
To read more, visit: Alzheimer's & Dementia
Alliance ViewsAdvancing Quantity and Quality of Life
In the August 12th issue of the New York Times, writer Nicholas Kristof editorialized on what he sees as the ambiguous, and often rogue nature of aging research.
Science in the SpotlightAge-Related Macular Degeneration
The eyes are the first to go, the old adage says.
What it is, what we know, what we need to learn
In an Alliance for Aging Research, National Alliance for Eye and Vision Research (NAEVR briefing, Dr. Michael Gorin presented on age-related maculopathy, an eye disease that affects millions of Americans. His presentation slides are available here.